PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10078541-1	1999	Sildenafil, a selective inhibitor of phosphodiesterase type 5 (PDE5), is the first in a new class of orally effective treatments for erectile dysfunction.	Sildenafil Citrate	0-10	phosphodiesterase 5A	Homo sapiens	37-61	
10078541-1	1999	Sildenafil, a selective inhibitor of phosphodiesterase type 5 (PDE5), is the first in a new class of orally effective treatments for erectile dysfunction.	Sildenafil Citrate	0-10	phosphodiesterase 5A	Homo sapiens	63-67	
10078541-3	1999	Sildenafil facilitates the erectile process during sexual stimulation by inhibiting PDE5 and thus blocking the breakdown of cGMP.	Sildenafil Citrate	0-10	phosphodiesterase 5A	Homo sapiens	84-88